Carmustine Kit
Product Images NDC 70710-1525

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Carmustine (NDC 70710-1525). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (D3a682d6 A3f2 4162 85e0 D0d603c5c00d 01)

FDA Label Image

Medication Guide (D3a682d6 A3f2 4162 85e0 D0d603c5c00d 02)

Medication Guide (D3a682d6 A3f2 4162 85e0 D0d603c5c00d 02)
These are instructions for using the Product Kit Guard for Carmustine for Injection, USP, 100 mg/vial, which is designed to protect user safety. The carmustine vial and sterile diluent come in two separate compartments of the guard. Gloves and syringes should be used and care should be taken when handling it. The Product Kit Guard should be discarded after use. Before using it, please refer to the enclosed product information leaflet. For more information, contact Zydus Pharmaceuticals USA Inc.*
FDA Label Image

Diluent Label (D3a682d6 A3f2 4162 85e0 D0d603c5c00d 03)

Diluent Label (D3a682d6 A3f2 4162 85e0 D0d603c5c00d 03)
The text contains some product information and a storage instruction for Dehydrated Alcohol Injection, USP. It mentions the storage requirement for the product to be in a refrigerator. Not much information is available about the product's usage or purpose.*
FDA Label Image

Lyo (D3a682d6 A3f2 4162 85e0 D0d603c5c00d 04)

Lyo (D3a682d6 A3f2 4162 85e0 D0d603c5c00d 04)
This is a description of the medication, Carmustine for Injection, USP. It's a single-dose vial containing 100mg of the medicine for intravenous infusion after reconstitution. The medication should be kept refrigerated and any unused portion should be discarded. After reconstitution, the medication is stable for 24 hours under refrigeration. If crystals are observed, they can be redissolved by warming the vial and protecting it from light. The package insert should be read for dosage and usage instructions, and the medication is not returnable. It is distributed by Zydus Pharmaceuticals USA Inc., located in Pennington, NJ 08534.*
FDA Label Image

Carton (D3a682d6 A3f2 4162 85e0 D0d603c5c00d 05)

Carton (D3a682d6 A3f2 4162 85e0 D0d603c5c00d 05)
This text is a product description of Carmustine for Injection, USP, which is a medication administered via intravenous infusion after reconstitution. It is refrigerated immediately and should only be used as indicated in the package insert. The usual dosage is indicated on the package insert. Each carton contains 1 vial of Carmustine for Injection, USP 100 mg and 1 vial of sterile diluent for Carmustine for Injection, USP 3 mL. Any unused portion should be discarded. The product should be stored in a refrigerator, and gloves should be worn when handling the containers.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.